Krishnan Nandabalan's Insider Trades & SAST Disclosures
Krishnan Nandabalan's most recent trade in BioXcel Therapeutics Inc was a trade of 60,000 Stock Options done . Disclosure was reported to the exchange on April 6, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Krishnan Nandabalan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2023 | 60,000 | 294,000 | - | - | Stock Options | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 06 Apr 2023 | 60,000 | 60,000 (0%) | 0% | 0.4 | 24,600 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 06 Apr 2023 | 60,000 | 0 (0%) | 0% | 17.3 | 1,039,200 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 34,111 | 379,889 | - | - | Stock Options | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 04 Jan 2023 | 34,111 | 34,111 (0%) | 0% | 0.4 | 13,986 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 25,889 | 354,000 | - | - | Stock Options | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 04 Jan 2023 | 25,889 | 25,889 (0%) | 0% | 0.4 | 10,614 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.32 per share. | 04 Jan 2023 | 25,089 | 800 (0%) | 0% | 22.3 | 559,986 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.59 per share. | 04 Jan 2023 | 24,290 | 9,821 (0%) | 0% | 21.6 | 524,421 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.21 per share. | 04 Jan 2023 | 9,821 | 0 (0%) | 0% | 22.2 | 218,124 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.93 per share. | 04 Jan 2023 | 800 | 0 (0%) | 0% | 22.9 | 18,344 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 291,097 | 8,546,750 (47%) | 1% | 0 | Common Stock | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 291,097 | 8,546,750 (47%) | 1% | 0 | Common Stock | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 145,549 | 8,546,750 (47%) | 0% | 0 | Common Stock | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 10 Nov 2022 | 32,550 | 0 (0%) | 0% | 15 | 488,250 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 10 Nov 2022 | 32,550 | 32,550 (0%) | 0% | 0.4 | 13,346 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 32,550 | 414,000 | - | - | Stock Options | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 10 Nov 2022 | 27,450 | 27,450 (0%) | 0% | 0.4 | 11,255 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 10 Nov 2022 | 27,450 | 0 (0%) | 0% | 15 | 411,750 | Common Stock |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 27,450 | 446,550 | - | - | Stock Options | |
| BioXcel Therapeutics Inc | Krishnan Nandabalan | Director | Sale of securities on an exchange or to another person at price $ 30.83 per share. | 25 Jun 2021 | 473,250 | 8,546,750 (47%) | 2% | 30.8 | 14,589,493 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges